Your browser doesn't support javascript.
loading
Metabolism of sulfur compounds in homocystinurias.
Kozich, Viktor; Ditrói, Tamás; Sokolová, Jitka; Krízková, Michaela; Krijt, Jakub; Jesina, Pavel; Nagy, Peter.
Afiliación
  • Kozich V; Department of Paediatrics and Adolescent Medicine, Charles University - First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
  • Ditrói T; Department of Molecular Immunology and Toxicology, National Institute of Oncology, Budapest, Hungary.
  • Sokolová J; Department of Paediatrics and Adolescent Medicine, Charles University - First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
  • Krízková M; Department of Paediatrics and Adolescent Medicine, Charles University - First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
  • Krijt J; Department of Paediatrics and Adolescent Medicine, Charles University - First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
  • Jesina P; Department of Paediatrics and Adolescent Medicine, Charles University - First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
  • Nagy P; Department of Molecular Immunology and Toxicology, National Institute of Oncology, Budapest, Hungary.
Br J Pharmacol ; 176(4): 594-606, 2019 02.
Article en En | MEDLINE | ID: mdl-30341787
ABSTRACT
BACKGROUND AND

PURPOSE:

Homocystinurias are rare genetic defects characterized by altered fluxes of sulfur compounds including homocysteine and cysteine. We explored whether the severely perturbed sulfur amino acid metabolism in patients with homocystinurias affects the metabolism of hydrogen sulfide. EXPERIMENTAL

APPROACH:

We studied 10 treated patients with a block in the conversion of homocysteine to cysteine due to cystathionine ß-synthase deficiency (CBSD) and six treated patients with remethylation defects (RMD) and an enhanced flux of sulfur metabolites via transsulfuration. Control groups for CBSD and RMD patients consisted of 22 patients with phenylketonuria on a low-protein diet and of 12 healthy controls respectively. Plasma and urine concentrations of selected sulfur compounds were analysed by HPLC and LC-MS/MS. KEY

RESULTS:

Patients with CBSD exhibited plasma concentrations of monobromobimane-detected sulfide similar to appropriate controls. Urinary homolanthionine and thiosulfate in CBSD were increased significantly 1.9 and 3 times suggesting higher hydrogen sulfide synthesis by γ-cystathionase and detoxification respectively. Surprisingly, patients with RMD had significantly lower plasma sulfide levels (53 and 64% of controls) with lower sulfite concentrations, and higher taurine and thiosulfate levels suggesting enhanced cysteine oxidation and hydrogen sulfide catabolism respectively. CONCLUSION AND IMPLICATIONS The results from this study suggest that severe inherited defects in sulfur amino acid metabolism may be accompanied by only moderately perturbed hydrogen sulfide metabolism and lends support to the hypothesis that enzymes in the transsulfuration pathway may not be the major contributors to the endogenous hydrogen sulfide pool. LINKED ARTICLES This article is part of a themed section on Chemical Biology of Reactive Sulfur Species. To view the other articles in this section visit http//onlinelibrary.wiley.com/doi/10.1111/bph.v176.4/issuetoc.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Azufre / Homocistinuria Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Br J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Azufre / Homocistinuria Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Br J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: República Checa